secwatch.observer — SEC 8-K summary
======================================

Issuer:     LB PHARMACEUTICALS INC (LBRX)
CIK:        0001691082
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001193125-25-202195
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LB Pharmaceuticals adopts amended charter and bylaws upon IPO closing on Sept 12, 2025
--------------------------------------------------------------------------------

- Filed amended and restated certificate of incorporation with Delaware Secretary of State.
- Adopted amended and restated bylaws effective immediately prior to IPO closing.
- Both documents previously approved by board and stockholders.
- IPO closed on September 12, 2025; common stock trades on Nasdaq under LBRX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/0001193125-25-202195-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1691082/000119312525202195/d32696d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-202195

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer